Article
Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice.
British journal of cancer - 1 Jun 2024
Tsoulaki Olga, Tischkowitz Marc, Antoniou Antonis C, Musgrave Hannah, Rea Gillian, Gandhi Ashu, Cox Karina, Irvine Tracey, Holcombe Sue, Eccles Diana, Turnbull Clare, Cutress Ramsey, Archer Stephanie, Hanson Helen
Abstract excerpt
BACKGROUND: The CanRisk tool, which operationalises the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) is used by Clinical Geneticists, Genetic Counsellors, Breast Oncologists, Surgeons and Family History Nurses for breast cancer risk assessments both nationally and internationally. There are currently no guidelines with respect to the day-to-day clinical application...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
